Determination of glycosaminoglycan levels by mass spectrometry
申请人:Shire Human Genetic Therapies, Inc.
公开号:US10578624B2
公开(公告)日:2020-03-03
Detecting glycosaminoglycans (GAGs) and/or determining the level of one or more glycosaminoglycans can be useful, e.g., in identifying or monitoring various medical conditions, the status of patients having various medical conditions, and/or the response to treatment of individuals having various medical conditions. The present invention provides methods for detecting glycosaminoglycans and/or determining the level of glycosaminoglycans through the use of, e.g., mass spectrometry.